Back
AbbVie Quote, Financials, Valuation and Earnings
Sponsored
ABBV
Sponsored
Earn Your Weekly "Paycheck" with Chuck's Secret Income Strategy!
Act now for your path to extra income!
Sell
42
ABBV
AbbVie
Last Price:
166.22
Seasonality Move:
4.33%
7 Day Trial
ALL ACCESS PASS
$
7
$50 trade to make today with huge potential!
Click here to access my #1 options strategy for overnight wins starting with $50!AbbVie Price Quote
$166.22
+1.56 (+0.95%)
(Updated: April 19, 2024 at 1:55 PM ET)
AbbVie Key Stats
Sell
42
AbbVie (ABBV)
is a Sell
Day range:
$164.43 - $167.44
52-week range:
$130.96 - $182.89
Dividend yield:
3.68%
P/E ratio:
60.54
P/S ratio:
5.38
P/B ratio:
28.08%
Volume:
4.5M
Avg. volume:
6.2M
1-year change:
3.18%
Market cap:
$290.9B
Revenue:
$54.3B
EPS:
$2.73
How Much Does AbbVie Make?
Is AbbVie Growing As A Company?
AbbVie Stock Price Performance
What Is AbbVie 52-Week High & Low?
AbbVie Price To Free Cash Flow
-
Is AbbVie Stock Overvalued?
AbbVie is trading at a price to free cash flow ratio of 13.24 -
Is AbbVie Stock Undervalued?
AbbVie EV to Free Cash Flow ratio is 15.30 -
What Is AbbVie’s Price Earnings Growth Ratio?
ABBV PEG ratio is 0.00 -
Is AbbVie Trading At A Premium To Earnings?
AbbVie EV to EBIT ratio is 39.82
Is It Risky To Buy AbbVie?
Is AbbVie Cash Flow Positive?
AbbVie Return On Invested Capital
AbbVie Earnings Date & Stock Price
-
What Is AbbVie's Stock Price Today?
A single share of ABBV can be purchased today for 164.66 -
What Is AbbVie’s Stock Symbol?
AbbVie trades on the S&P500 under the ticker symbol: ABBV -
When Is AbbVie’s Next Earnings Date?
The next quarterly earnings date for AbbVie is scheduled on April 26, 2024 -
When Is ABBV's next ex-dividend date?
AbbVie's next ex-dividend date is April 12, 2024 -
How To Buy AbbVie Stock?
You can buy AbbVie shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
AbbVie Competitors
AbbVie Dividend Yield
AbbVie Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | -66.67% | -0.32% |
Revenue: | -5.42% | 1.96% |
Analyst Recommendations
Buy Recommendations: | 8 |
---|---|
Hold Recommendations: | 13 |
Sell Recommendations: | 0 |
Price Target: | 183.96 |
Upside from Last Price: | 11.72% |